
𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗻𝗴 𝗔𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗦𝘁𝗮𝗰𝗸: 𝗙𝗿𝗼𝗺 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗥𝗶𝘀𝗸 𝘁𝗼 𝗦𝗰𝗮𝗹𝗮𝗯𝗹𝗲 𝗜𝗺𝗽𝗮𝗰𝘁 | 𝗣𝗮𝗻𝗲𝗹 𝗗𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻 — 𝗧𝗲𝗰𝗵𝗖𝗼𝗻 𝗦𝗼𝘂𝘁𝗵𝘄𝗲𝘀𝘁 𝟮𝟬𝟮𝟲
When the data is thin and the science is complex — how do investors still make the call?
This panel from TechCon Southwest 2026 brought together experienced investors and physician-operators to explore how they assess risk, identify inflection points, and back companies across biotech, genomics, digital health, and healthcare systems.
𝗔 𝗳𝗲𝘄 𝗸𝗲𝘆 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻:
• Early-stage life sciences investing is more art than science — with limited data, investors rely heavily on pattern recognition and referenceable frameworks.
• The real innovation in life sciences often happens before formal disclosure — engaging advisors early is key to identifying what's truly differentiated.
• Fixing the system of medicine, not just the practice of it, is where technology can drive the most meaningful and measurable outcomes.
• Founders in this space must balance scientific risk with clinical reality, regulatory pathways, and commercial scalability all at once.
A comprehensive look at how investors and operators are navigating one of the most complex and high-stakes sectors in the Texas innovation ecosystem.
🎥 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗮𝗻𝗲𝗹 𝗱𝗶𝘀𝗰𝘂𝘀𝘀𝗶𝗼𝗻 𝗵𝗲𝗿𝗲: youtu.be/8FuhzA8QACY?si…
📲 𝗙𝗼𝗹𝗹𝗼𝘄 𝗼𝘂𝗿 𝗪𝗵𝗮𝘁𝘀𝗔𝗽𝗽 𝗖𝗵𝗮𝗻𝗻𝗲𝗹 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝘀𝗲𝘀𝘀𝗶𝗼𝗻𝘀, 𝘂𝗽𝗱𝗮𝘁𝗲𝘀, 𝗮𝗻𝗱 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗧𝗲𝗰𝗵𝗖𝗼𝗻 𝗚𝗹𝗼𝗯𝗮𝗹 → whatsapp.com/channel/0029Vb…
#TechCon #TechConSouthWest #LifeSciences #DigitalHealth #Biotech #HealthTech #VentureCapital #Founders #Austin #Texas

YouTube
English


















